Hepatosplenic T-cell lymphoma following linfliximab therapy for Crohn's disease

被引:22
作者
Drini, Musa [1 ]
Prichard, Peter J. [2 ]
Brown, Gregor J. E. [2 ]
Macrae, Finlay A. [1 ]
机构
[1] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
关键词
D O I
10.5694/j.1326-5377.2008.tb02124.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Tumour necrosis factor inhibitors have revolutionised the management of Crohn's disease, but reports of a possible association between concomitant infliximab and immunomodulator therapy and hepatosplenic T-cell lymphoma (a rare form of aggressive non-Hodgkin's lymphoma) have emerged. We describe the first case in Australia of hepatosplenic T-cell lymphoma in a patient who had been treated with infliximab and immunomodulators for Crohn's disease. (MJA 2008; 189: 464-465)
引用
收藏
页码:464 / 465
页数:2
相关论文
共 8 条
[1]
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].
Bongartz, T ;
Sutton, AJ ;
Sweeting, MJ ;
Buchan, I ;
Matteson, EL ;
Montori, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285
[2]
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease [J].
Corken Mackey, Ann ;
Green, Lanh ;
Liang, Li-ching ;
Dinndorf, Patricia ;
Avigan, Mark .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (02) :265-267
[3]
Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma [J].
He, Simon ;
Roberts, Andrew ;
Ritchie, David ;
Grigg, Andrew .
LEUKEMIA & LYMPHOMA, 2007, 48 (07) :1448-1450
[4]
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry [J].
Lichtenstein, GR ;
Feagan, BG ;
Cohen, RD ;
Salzberg, BA ;
Diamond, RH ;
Chen, DM ;
Pritchard, ML ;
Sandborn, WJ .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (05) :621-630
[5]
Current and future anti-TNF therapy for inflammatory bowel disease [J].
Osterman M.T. ;
Lichtenstein G.R. .
Current Treatment Options in Gastroenterology, 2007, 10 (3) :195-207
[6]
BIAS IN ANALYTIC RESEARCH [J].
SACKETT, DL .
JOURNAL OF CHRONIC DISEASES, 1979, 32 (1-2) :51-63
[7]
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy [J].
Zeidan, Amer ;
Sham, Ronald ;
Shapiro, Joel ;
Baratta, Anthony ;
Kouides, Peter .
LEUKEMIA & LYMPHOMA, 2007, 48 (07) :1410-1413
[8]
2006, AUST ADVERSE DRUG RE, V25, P23